deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03350737

Coronary Arteriogenetic Heparinized Exercise (CARHEXA)

Coronary ARteriogenesis With Combined Heparin and EXercise Therapy in Chronic Refractory Angina

Sponsor: Clinical Centre of Serbia

Updated 7 times since 2017 Last updated: May 12, 2020 Started: Feb 1, 2013 Primary completion: Dec 31, 2019 Completion: Dec 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Chronic Stable Angina and Refractory Angina, this trial is completed. The trial is conducted by Clinical Centre of Serbia and has accumulated 7 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotRecruiting~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshotRecruiting~Mar 2019 – ~Jun 2020 · 15 months · monthly snapshotRecruiting~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2020 — Jan 2021 [monthly]

    Completed NA

    Status: RecruitingCompleted

  5. Mar 2019 — Jun 2020 [monthly]

    Recruiting NA

Show 2 earlier versions
  1. Jun 2018 — Mar 2019 [monthly]

    Recruiting NA

  2. Dec 2017 — Jun 2018 [monthly]

    Recruiting NA

    First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Clinical Centre of Serbia
  • Fondazione C.N.R./Regione Toscana G. Monasterio, Pisa, Italy
Data source: Clinical Centre of Serbia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations